Active ingredient prescribing

The Active ingredient prescribing (AIP) initiative helps ensure consistent information about prescription medicines is used when health practitioners prescribe and dispense medicines for their patients.

About the initiative

AIP is part of a wider government initiative to ensure consistent information about prescription medicines. Learn more about the program and why it is important.

Active and inactive ingredients

Learn about what is, and what is not an active ingredient in prescription medicines.

When AIP applies

Active ingredient prescribing (AIP) is mandatory for prescription medication listed on the Pharmaceutical Benefits Schedule (PBS) and the Repatriation Schedule of Pharmaceutical Benefits (RPBS).

The LEMI and LMBC

The List of Excluded Medicinal Items (LEMI) and the List of Medicines for Brand Consideration (LMBC) help support prescribers to prescribe medicines by the active ingredient with best practice guidance for specification of brand.

List of Excluded Medicinal Items

See medicines that are excluded from the legal requirements of active ingredient prescribing.

List of Medicines for Brand Consideration

See medicines prescribers should consider prescribing by brand in addition to active ingredient.

Outcomes Register

See a record of the Active Ingredient Prescribing Working Group (AIPWG) review of specific medicines.

Latest resources

Date last updated:
Tags: 

Help us improve health.gov.au

If you would like a response please use the enquiries form instead.